Immediate Impact

61 standout
Sub-graph 1 of 20

Citing Papers

Multifunctional nanoparticle-mediated combining therapy for human diseases
2024 Standout
Treatment algorithm for pulmonary arterial hypertension
2024 Standout
26 intermediate papers

Works of F. Kermeen being referenced

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study)
2012
Endothelin Receptor Antagonists are an Effective Long Term Treatment Option in Pulmonary Arterial Hypertension Associated with Congenital Heart Disease With or Without Trisomy 21
2010
and 2 more

Author Peers

Author Last Decade Papers Cites
F. Kermeen 749 167 510 199 44 955
Roberto Poscia 910 101 754 200 52 1.1k
Laurent Godinas 808 229 448 125 64 1.1k
Thierry Fourme 479 207 527 195 21 873
Abubakr Bajwa 658 234 231 144 46 976
Michał Florczyk 838 139 623 130 40 987
Todd Bull 519 141 346 130 35 955
Andrew Van Tosh 475 177 645 151 44 988
D. De Zuttère 520 120 373 160 25 926
Christian Gerges 918 127 812 132 41 1.1k
Anjali Vaidya 780 179 673 138 55 1.1k

All Works

Loading papers...

Rankless by CCL
2026